SS Innovations International vs Stereotaxis
SSII and STXS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SSII and STXS compare
SS Innovations International is the larger company, worth 3.0 times as much as Stereotaxis ($267M against $88.4M).
SS Innovations International grew revenue faster over the last twelve months (89.7% versus −5.5% for Stereotaxis).
SS Innovations International keeps more of each dollar of sales as profit, with a net margin of −23.7% compared with −74.2% at Stereotaxis.
SS Innovations International scores higher on the StockData Score (8 against 7 for Stereotaxis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SSII | STXS |
|---|---|---|
| Size and price | ||
| Market cap | $267M | $88.4M |
| Share price | $1.33 | $0.882 |
| Change, 1 year | −78.6% | −60.3% |
| Change, 5 years | – | −85.2% |
| Beta (5Y) | 0.90 | 1.00 |
| Employees | 81 | 131 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 5.1× | 2.9× (better) |
| P/B | 5.0× (better) | 7.2× |
| FCF yield | – | −17.5% |
| Fair value | $3.56 | $1.08 |
| Margin of safety | 62.6% (better) | 18.0% |
| Growth | ||
| Revenue growth (TTM) | 89.7% (better) | −5.5% |
| Revenue growth, 5Y average | – | 4.0% |
| Profitability | ||
| Gross margin | 47.6% | 55.6% (better) |
| Operating margin | −16.2% (better) | −75.7% |
| Net margin | −23.7% (better) | −74.2% |
| FCF margin | – | −51.6% |
| Return on equity | −26.1% (better) | −326% |
| Return on invested capital | −20.9% | – |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −7.4× | – |
| Current ratio | 2.24 (better) | 1.42 |
| Altman Z-score | 3.52 (better) | −14.13 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | – | −24.0% |
| Shareholder yield | 0.00% (better) | −24.0% |
| Ownership | ||
| Held by institutions | 0.82% | 43.0% |
| Held by insiders | 76.7% | 20.3% |
| Insider net buying, 12 months | $5.1M (better) | $0 |
| Short interest, % of float | 0.14% | 7.0% |
Go deeper
- SSII stock overview
- SSII income statement
- SSII valuation and score
- STXS stock overview
- STXS income statement
- STXS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.